Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 47 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Development of an assay for the detection of mucopolysaccharidosis type VI patients using dried blood-spotsHein, L.; Meikle, P.; Dean, C.; Bockmann, M.; Auclair, D.; Hopwood, J.; Brooks, D.
2007Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapyKarageorgos, L.; Brooks, D.; Harmatz, P.; Ketteridge, D.; Pollard, A.; Melville, E.; Parkinson-Lawrence, E.; Clements, P.; Hopwood, J.
2005An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrumBrooks, D.; Gibson, G.; Karageorgos, L.; Hein, L.; Robertson, E.; Hopwood, J.
2004Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patientsParkinson, E.; Muller, V.; Hopwood, J.; Brooks, D.
1999Autologous transplantation of retrovirally transduced bone marrow or neonatal blood cells into cats can lead to long-term engraftment in the absence of myeloablationSimonaro, C.; Haskins, M.; Abkowitz, J.; Brooks, D.; Hopwood, J.; Zhang, J.B.; Schuchman, E.
2002Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): A Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar networkBradford, T.; Litjens, T.; Parkinson, E.; Hopwood, J.; Brooks, D.
2012Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI catsPonder, K.; O'Malley, T.; Wang, P.; O'Donnell, P.; Traas, A.; Knox, V.; Aguirre, G.; Ellinwood, N.; Metcalf, J.; Wang, B.; Parkinson-Lawrence, E.; Sleeper, M.; Brooks, D.; Hopwood, J.; Haskins, M.
2001Glycosidase active site mutations in human a-L-iduronidaseBrooks, D.; Fabrega, S.; Hein, L.; Parkinson, E.; Durand, P.; Yogalingam, G.; Matte, U.; Giugliani, R.; Dasvarma, A.; Eslahpazire, J.; Henrissat, B.; Mornon, J.; Hopwood, J.; Lehn, P.
2001Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of a-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulationKeeling, K.; Brooks, D.; Hopwood, J.; Li, P.; Thompson, J.; Bedwell, D.
1995In vivo delivery of human α-L-iduronidase in mice implanted with neo-organsSalvetti, A.; Moullier, P.; Cornet, V.; Brooks, D.; Hopwood, J.; Danos, O.; Heard, J.M.